Fingolimod approved!

…and so just a follow up on my previoud posts…

Fingolimod (Gilenya) has finally been approved by the FDA. Gilenya (fingolimod) is a 0.5 mg (capsule) daily oral treatment for relapsing MS.

Novartis, stated that Gilenya is the first oral medication indicated for relapsing forms of multiple sclerosis (MS) in the United States – it reduces the frequency of MS flare-up, as well as helping slow down the build-up of some of the physical problems associated with MS.

Yeay! more oral drugs – we like! : )

Advertisements

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: